PDB Short entry for 3CGO HEADER TRANSFERASE 06-MAR-08 3CGO TITLE IRAK-4 INHIBITORS (PART II)- A STRUCTURE BASED ASSESSMENT OF TITLE 2 IMIDAZO[1,2 A]PYRIDINE BINDING COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 10; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PROTEIN KINASE DOMAIN, UNP RESIDUES 40-402; COMPND 5 SYNONYM: STRESS-ACTIVATED PROTEIN KINASE JNK3, C-JUN N-TERMINAL COMPND 6 KINASE 3, MAP KINASE P49 3F12; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 GENE: MAPK10, JNK3, JNK3A, PRKM10; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI KEYWDS JNK3 KINASE, INHIBITOR, ALTERNATIVE SPLICING, ATP-BINDING, KEYWDS 2 CHROMOSOMAL REARRANGEMENT, CYTOPLASM, EPILEPSY, NUCLEOTIDE-BINDING, KEYWDS 3 PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.A.CESKA,A.PLATT,M.FORTUNATO,K.M.DICKSON,R.BEEVERS REVDAT 5 01-NOV-23 3CGO 1 REMARK SEQADV REVDAT 4 25-OCT-17 3CGO 1 REMARK REVDAT 3 24-FEB-09 3CGO 1 VERSN REVDAT 2 10-JUN-08 3CGO 1 JRNL REVDAT 1 03-JUN-08 3CGO 0 JRNL AUTH G.M.BUCKLEY,T.A.CESKA,J.L.FRASER,L.GOWERS,C.R.GROOM, JRNL AUTH 2 A.P.HIGUERUELO,K.JENKINS,S.R.MACK,T.MORGAN,D.M.PARRY, JRNL AUTH 3 W.R.PITT,O.RAUSCH,M.D.RICHARD,V.SABIN JRNL TITL IRAK-4 INHIBITORS. PART II: A STRUCTURE-BASED ASSESSMENT OF JRNL TITL 2 IMIDAZO[1,2-A]PYRIDINE BINDING JRNL REF BIOORG.MED.CHEM.LETT. V. 18 3291 2008 JRNL REFN ISSN 0960-894X JRNL PMID 18482836 JRNL DOI 10.1016/J.BMCL.2008.04.039 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 99999.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 89.1 REMARK 3 NUMBER OF REFLECTIONS : 12974 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.243 REMARK 3 R VALUE (WORKING SET) : 0.243 REMARK 3 FREE R VALUE : 0.318 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1334 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2703 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 54 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.230 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.28 REMARK 3 BSOL : 27.10 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : J10.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : J10.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3CGO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-MAR-08. REMARK 100 THE DEPOSITION ID IS D_1000046754. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-AUG-04 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13086 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.4 REMARK 200 DATA REDUNDANCY : 8.890 REMARK 200 R MERGE (I) : 0.09800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 59.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.49800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: PDB ENTRY 1JNK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH7.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.11000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.86000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.88500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.86000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.11000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.88500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 38 REMARK 465 GLY A 39 REMARK 465 SER A 40 REMARK 465 LYS A 41 REMARK 465 SER A 42 REMARK 465 LYS A 43 REMARK 465 VAL A 44 REMARK 465 ARG A 212 REMARK 465 THR A 213 REMARK 465 ALA A 214 REMARK 465 GLY A 215 REMARK 465 THR A 216 REMARK 465 ASP A 364 REMARK 465 PRO A 365 REMARK 465 ALA A 366 REMARK 465 GLU A 367 REMARK 465 VAL A 368 REMARK 465 GLU A 369 REMARK 465 ALA A 370 REMARK 465 PRO A 371 REMARK 465 PRO A 372 REMARK 465 PRO A 373 REMARK 465 GLN A 374 REMARK 465 ILE A 375 REMARK 465 TYR A 376 REMARK 465 ASP A 377 REMARK 465 LYS A 378 REMARK 465 GLN A 379 REMARK 465 LEU A 380 REMARK 465 ASP A 381 REMARK 465 GLU A 382 REMARK 465 SER A 401 REMARK 465 GLU A 402 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 48 -162.94 -123.60 REMARK 500 ASP A 55 -8.04 -144.73 REMARK 500 GLN A 75 -17.24 -145.26 REMARK 500 CYS A 117 -78.60 -73.31 REMARK 500 ILE A 124 124.01 -26.37 REMARK 500 PHE A 139 130.44 -33.76 REMARK 500 GLN A 140 -63.69 -139.09 REMARK 500 ASP A 189 40.57 -143.82 REMARK 500 LEU A 206 -72.60 -83.67 REMARK 500 ASN A 243 9.73 -63.67 REMARK 500 GLN A 291 153.69 -47.34 REMARK 500 PRO A 314 -163.06 -63.26 REMARK 500 ALA A 320 46.51 -145.73 REMARK 500 ASN A 360 -9.15 -58.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE JNO A 510 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2P33 RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEX WITH A DIFFERENT LIGAND REMARK 900 RELATED ID: 3CGF RELATED DB: PDB DBREF 3CGO A 40 402 UNP P53779 MK10_HUMAN 40 402 SEQADV 3CGO MET A 38 UNP P53779 EXPRESSION TAG SEQADV 3CGO GLY A 39 UNP P53779 EXPRESSION TAG SEQRES 1 A 365 MET GLY SER LYS SER LYS VAL ASP ASN GLN PHE TYR SER SEQRES 2 A 365 VAL GLU VAL GLY ASP SER THR PHE THR VAL LEU LYS ARG SEQRES 3 A 365 TYR GLN ASN LEU LYS PRO ILE GLY SER GLY ALA GLN GLY SEQRES 4 A 365 ILE VAL CYS ALA ALA TYR ASP ALA VAL LEU ASP ARG ASN SEQRES 5 A 365 VAL ALA ILE LYS LYS LEU SER ARG PRO PHE GLN ASN GLN SEQRES 6 A 365 THR HIS ALA LYS ARG ALA TYR ARG GLU LEU VAL LEU MET SEQRES 7 A 365 LYS CYS VAL ASN HIS LYS ASN ILE ILE SER LEU LEU ASN SEQRES 8 A 365 VAL PHE THR PRO GLN LYS THR LEU GLU GLU PHE GLN ASP SEQRES 9 A 365 VAL TYR LEU VAL MET GLU LEU MET ASP ALA ASN LEU CYS SEQRES 10 A 365 GLN VAL ILE GLN MET GLU LEU ASP HIS GLU ARG MET SER SEQRES 11 A 365 TYR LEU LEU TYR GLN MET LEU CYS GLY ILE LYS HIS LEU SEQRES 12 A 365 HIS SER ALA GLY ILE ILE HIS ARG ASP LEU LYS PRO SER SEQRES 13 A 365 ASN ILE VAL VAL LYS SER ASP CYS THR LEU LYS ILE LEU SEQRES 14 A 365 ASP PHE GLY LEU ALA ARG THR ALA GLY THR SER PHE MET SEQRES 15 A 365 MET THR PRO TYR VAL VAL THR ARG TYR TYR ARG ALA PRO SEQRES 16 A 365 GLU VAL ILE LEU GLY MET GLY TYR LYS GLU ASN VAL ASP SEQRES 17 A 365 ILE TRP SER VAL GLY CYS ILE MET GLY GLU MET VAL ARG SEQRES 18 A 365 HIS LYS ILE LEU PHE PRO GLY ARG ASP TYR ILE ASP GLN SEQRES 19 A 365 TRP ASN LYS VAL ILE GLU GLN LEU GLY THR PRO CYS PRO SEQRES 20 A 365 GLU PHE MET LYS LYS LEU GLN PRO THR VAL ARG ASN TYR SEQRES 21 A 365 VAL GLU ASN ARG PRO LYS TYR ALA GLY LEU THR PHE PRO SEQRES 22 A 365 LYS LEU PHE PRO ASP SER LEU PHE PRO ALA ASP SER GLU SEQRES 23 A 365 HIS ASN LYS LEU LYS ALA SER GLN ALA ARG ASP LEU LEU SEQRES 24 A 365 SER LYS MET LEU VAL ILE ASP PRO ALA LYS ARG ILE SER SEQRES 25 A 365 VAL ASP ASP ALA LEU GLN HIS PRO TYR ILE ASN VAL TRP SEQRES 26 A 365 TYR ASP PRO ALA GLU VAL GLU ALA PRO PRO PRO GLN ILE SEQRES 27 A 365 TYR ASP LYS GLN LEU ASP GLU ARG GLU HIS THR ILE GLU SEQRES 28 A 365 GLU TRP LYS GLU LEU ILE TYR LYS GLU VAL MET ASN SER SEQRES 29 A 365 GLU HET JNO A 510 27 HETNAM JNO 2-{4-[(4-IMIDAZO[1,2-A]PYRIDIN-3-YLPYRIMIDIN-2-YL) HETNAM 2 JNO AMINO]PIPERIDIN-1-YL}-N-METHYLACETAMIDE FORMUL 2 JNO C19 H23 N7 O FORMUL 3 HOH *54(H2 O) HELIX 1 1 ASN A 101 MET A 115 1 15 HELIX 2 2 LEU A 153 GLN A 158 1 6 HELIX 3 3 ASP A 162 ALA A 183 1 22 HELIX 4 4 LYS A 191 SER A 193 5 3 HELIX 5 5 ALA A 231 LEU A 236 1 6 HELIX 6 6 ASN A 243 HIS A 259 1 17 HELIX 7 7 ASP A 267 LEU A 279 1 13 HELIX 8 8 CYS A 283 LYS A 288 1 6 HELIX 9 9 GLN A 291 ASN A 300 1 10 HELIX 10 10 THR A 308 PHE A 313 1 6 HELIX 11 11 SER A 322 LEU A 340 1 19 HELIX 12 12 ASP A 343 ARG A 347 5 5 HELIX 13 13 SER A 349 LEU A 354 1 6 HELIX 14 14 ILE A 359 TYR A 363 5 5 HELIX 15 15 THR A 386 MET A 399 1 14 SHEET 1 A 2 PHE A 48 GLU A 52 0 SHEET 2 A 2 THR A 57 LEU A 61 -1 O PHE A 58 N VAL A 51 SHEET 1 B 5 TYR A 64 SER A 72 0 SHEET 2 B 5 ILE A 77 ASP A 83 -1 O ALA A 80 N LYS A 68 SHEET 3 B 5 ARG A 88 SER A 96 -1 O ILE A 92 N CYS A 79 SHEET 4 B 5 ASP A 141 GLU A 147 -1 O LEU A 144 N LYS A 93 SHEET 5 B 5 LEU A 126 PHE A 130 -1 N PHE A 130 O TYR A 143 SHEET 1 C 3 ALA A 151 ASN A 152 0 SHEET 2 C 3 ILE A 195 VAL A 197 -1 O VAL A 197 N ALA A 151 SHEET 3 C 3 LEU A 203 ILE A 205 -1 O LYS A 204 N VAL A 196 SITE 1 AC1 8 ILE A 70 ALA A 91 GLU A 147 MET A 149 SITE 2 AC1 8 ASP A 150 ALA A 151 GLN A 155 HOH A 517 CRYST1 52.220 71.770 107.720 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019150 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013933 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009283 0.00000